Market open
CytoMed Therapeutics Limited/$GDTC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Ticker
$GDTC
Sector
Trading on
Industry
Biotechnology
Headquarters
Singapore, Singapore
Employees
43
ISIN
SGXZ17669631
Website
GDTC Metrics
BasicAdvanced
$27M
-
-$0.17
-0.29
-
Price and volume
Market cap
$27M
Beta
-0.29
52-week high
$2.85
52-week low
$1.98
Average daily volume
22K
Financial strength
Current ratio
9.892
Quick ratio
8.393
Long term debt to equity
4.615
Total debt to equity
5.122
Interest coverage (TTM)
-154.11%
Management effectiveness
Return on assets (TTM)
-17.44%
Return on equity (TTM)
-24.86%
Valuation
Price to revenue (TTM)
69.957
Price to book
3.02
Price to tangible book (TTM)
3.06
Price to free cash flow (TTM)
-8.376
Growth
Revenue change (TTM)
-0.86%
Earnings per share change (TTM)
-43.91%
3-year revenue growth (CAGR)
64.13%
3-year earnings per share growth (CAGR)
-9.67%
GDTC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for CytoMed Therapeutics Limited stock?
CytoMed Therapeutics Limited (GDTC) has a market cap of $27M as of May 15, 2025.
What is the P/E ratio for CytoMed Therapeutics Limited stock?
The price to earnings (P/E) ratio for CytoMed Therapeutics Limited (GDTC) stock is 0 as of May 15, 2025.
Does CytoMed Therapeutics Limited stock pay dividends?
No, CytoMed Therapeutics Limited (GDTC) stock does not pay dividends to its shareholders as of May 15, 2025.
When is the next CytoMed Therapeutics Limited dividend payment date?
CytoMed Therapeutics Limited (GDTC) stock does not pay dividends to its shareholders.
What is the beta indicator for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited (GDTC) has a beta rating of -0.29. This means that it has an inverse relation to market volatility.